Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 10, 2017
Complexity in Acid-Base Titrations: Multimer Formation Between Phosphoric Acids and Imines
Christian Malm, Heejae Kim, Manfred Wagner, et al.
The Journal of Physical Chemistry. B
|
July 24, 2020
Composition-Dependent Hydrogen-Bonding Motifs and Dynamics in Brønsted Acid-Base Mixtures
Christian Malm, Leon A Prädel, Bogdan A Marekha, et al.
Angewandte Chemie (International Ed. in English)
|
November 8, 2018
Specific Ion Effects on an Oligopeptide: Bidentate Binding Matters for the Guanidinium Cation
Vasileios Balos, Bogdan Marekha, Christian Malm, et al.
Dalton Transactions (Cambridge, England : 2003)
|
June 1, 2018
Tritopic ion-pair receptors based on anion-π interactions for selective CaX<sub>2</sub> binding
Jian Luo, Yu-Fei Ao, Christian Malm, et al.
Lakartidningen
|
November 25, 2003
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]
Matti Lehtinen, Christian Malm, Dan Apter, et al.
Scandinavian Journal of Infectious Diseases
|
November 26, 2005
High prevalence of HPV among female students in Finland
Eeva Auvinen, Marja Niemi, Christian Malm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2017
Nanoparticle amount, and not size, determines chain alignment and nonlinear hardening in polymer nanocomposites
H Samet Varol, Fanlong Meng, Babak Hosseinkhani, et al.
Vaccine
|
May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Sven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
The Lancet. Oncology
|
May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Vaccine
|
June 7, 2006
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L Villa, Kevin A Ault, Anna R Giuliano, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 10, 2017
Complexity in Acid-Base Titrations: Multimer Formation Between Phosphoric Acids and Imines
Christian Malm, Heejae Kim, Manfred Wagner, et al.
The Journal of Physical Chemistry. B
|
July 24, 2020
Composition-Dependent Hydrogen-Bonding Motifs and Dynamics in Brønsted Acid-Base Mixtures
Christian Malm, Leon A Prädel, Bogdan A Marekha, et al.
Angewandte Chemie (International Ed. in English)
|
November 8, 2018
Specific Ion Effects on an Oligopeptide: Bidentate Binding Matters for the Guanidinium Cation
Vasileios Balos, Bogdan Marekha, Christian Malm, et al.
Dalton Transactions (Cambridge, England : 2003)
|
June 1, 2018
Tritopic ion-pair receptors based on anion-π interactions for selective CaX<sub>2</sub> binding
Jian Luo, Yu-Fei Ao, Christian Malm, et al.
Lakartidningen
|
November 25, 2003
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]
Matti Lehtinen, Christian Malm, Dan Apter, et al.
Scandinavian Journal of Infectious Diseases
|
November 26, 2005
High prevalence of HPV among female students in Finland
Eeva Auvinen, Marja Niemi, Christian Malm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2017
Nanoparticle amount, and not size, determines chain alignment and nonlinear hardening in polymer nanocomposites
H Samet Varol, Fanlong Meng, Babak Hosseinkhani, et al.
Vaccine
|
May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Sven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
The Lancet. Oncology
|
May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Vaccine
|
June 7, 2006
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L Villa, Kevin A Ault, Anna R Giuliano, et al.
Page
of 1